BioWorld BioWorld MedTech BioWorld Asia BioWorld Science

BioWorld

Spring cleaning starts early as Sanofi and others cut programs
It’s the season for reevaluation as companies weed out programs that don’t offer much promise. At the head of the line is Sanofi SA’s once-potential myasthenia gravis...

More in BioWorld

BioWorld MedTech

Dxcover reveals $12M in new funding for multi-cancer early detection platform
Dxcover Ltd. raised $9.25 million (£7.5 million) in a series A fundraising round and received a grant of $2.7 million (£2.2 million) from the European Innovation Council to...

More in BioWorld MedTech

BioWorld Science

Cancer progression pathway and possible therapy for Fanconi anemia identified
Results from a French study of a cohort of individuals with the inherited rare disease Fanconi anemia shed light on how some people with this condition go on to develop...

More in BioWorld Science

BioWorld Asia

CS Pharma gains Chinese rights to Daewoong’s antifibrotic agent, bersiporocin, in $336M deal
Daewoong Pharmaceutical Ltd. has out-licensed greater China rights for its idiopathic pulmonary fibrosis (IPF) candidate, bersiporocin (DWN-2088), to CS Pharmaceuticals...

More in BioWorld Asia

BioWorld Insider Podcast

BioWorld Science Managing Editor Anette Breindl discusses her new analysis of multiple studies related to weight loss, metabolic health and fitness which in many ways goes against the mainstream health care state of mind about obesity.